PainDrainer AB invited as a speaker at the 2021 World Congress on Pain

Report this content

LUND, SWEDEN – PainDrainer AB announces that the company will participate in the conference International Association for the study of Pain (IASP) 2021 World Congress on Pain June 9-11 and 16-18 where the company’s Chief Medical Officer (CMO), also Chairman of the Board, Prof. Carl Borrebaeck is an invited speaker to present the results of PainDrainer’s pilot study conducted at the Koman Family Outpatient Clinic at UC San Diego Health.

PainDrainer® is the first digital app powered by artificial intelligence, which makes it completely patient-centric, as it adapts to each individual patient’s needs.
“We are incredibly pleased with the results which show that already after about 6 weeks of use, PainDrainer® provides a significant improvement in quality of life and a reduction in pain intensity for chronic pain patients.”, says Carl Borrebaeck, CMO PainDrainer AB.
The pilot study was conducted in together with Koman Family Outpatient Clinic at UC San Diego Health. “Our work focuses on helping patients manage their chronic pain. PainDrainer™ is a novel approach in our clinic and has made it possible for us to improve the quality of life for the patients included in the study. It has been exiting to test PainDrainer's patient-centric digital tool, which in our study has achieved very positive results”, says Gregory R. Polston MD, Pain Management Specialist, UC San Diego Health.
“This is an important milestone for the company and is the first study to show clinical evidence of an artificial intelligence powered digital tool tailored for chronic pain patients. The result validates the promising development of the company's current and future products, and I am incredibly pleased with the outcome of this first clinical study”, says Ann-Christin Malmborg Hager CEO at PainDrainer AB.
The scientific poster can be read on PainDrainer’s website where the presentation will also be available afterwards.

For more information, please contact:
Ann-Christin Malmborg Hager CEO PainDrainer AB

About PainDrainer AB
PainDrainer AB is a company that develops digital platforms and applications contributing to health and well-being. PainDrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Klement (herself a chronic pain patient), and Göran Barkfors (IT specialist). The idea was born when Maria, after participating in several pain rehabilitation programs, realized that the pain is affected by more factors than the human brain can keep track of, as on day is rarely the same as the other. Leading hospitals and pain specialists in Scandinavia and the USA have contributed to the development of PainDrainer™
PainDrainer™ uses advanced calculations based on artificial intelligence to coach the user in planning their day not to exceed a certain pain level, and to ensure that there is energy left for activities highly valued.
PainDrainer™ has clinical evidence, is based on Acceptance and Commitment Therapy (ACT), self-management and artificial intelligence (AI). It is CE certified and is cleared by FDA as a Mobile Medical Device class 1 with exemption.